Cue Biopharma, Inc. (CUE) Operating cash flow 2017–2025
Cue Biopharma, Inc. (CUE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$21.7MFY2025 · since FY2017: -$12.1M → -$21.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$21.7M | +40.3% |
| FY2024 | -$36.3M | +9.1% |
| FY2023 | -$40.0M | +4.4% |
| FY2022 | -$41.8M | -7.6% |
| FY2021 | -$38.8M | -19.5% |
| FY2020 | -$32.5M | -5.5% |
| FY2019 | -$30.8M | -16.6% |
| FY2018 | -$26.4M | -117.5% |
| FY2017 | -$12.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice